Tenofovir-associated Fanconi syndrome in patients with chronic hepatitis B monoinfection

71Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Tenofovir disoproxil fumarate (TDF) is increasingly used in patients with chronic hepatitis B (CHB) infection. Although associated with renal toxicity in HIV-infected patients, renal dysfunction has been reported rarely in the monoinfected CHB population. To date, TDF-associated Fanconi syndrome has not been reported. Here, we present two cases of TDF-associated Fanconi syndrome with rapid resolution after its cessation. We then discuss risk factors for TDF nephrotoxicity and its implications for screening for renal disease in those patients with CHB monoinfection on TDF, and the use of TDF in at-risk populations. © 2013 International Medical Press.

Cite

CITATION STYLE

APA

Gracey, D. M., Snelling, P., McKenzie, P., & Strasser, S. I. (2013). Tenofovir-associated Fanconi syndrome in patients with chronic hepatitis B monoinfection. Antiviral Therapy, 18(7), 945–948. https://doi.org/10.3851/IMP2649

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free